NEW YORK, March 17, 2022--Manhattan Scientifics Inc. (OTCQB: MHTX ), announces positive early results from Imagion Biosystems Cancer Diagnostic human study.
NEW YORK, November 01, 2021--Manhattan Scientifics Inc. (OTC: QB), initially funded and is the current owner of more that 50 million shares of Imagion Biosystems Ltd. (IBX.AX).